News and Events

 

Stay up to date with news and events

Phase 1 results announced for Skyhawk’s drug SKY-0515

Skyhawk Therapeutics shared results for SKY-0515, a drug designed to lower huntingtin. The drug appeared generally safe, with 60% reduction of huntingtin in blood at…

Huntington’s Disease Community Advocacy Helps Land Critical FDA Meeting for AMT-130

⏱️5 min read |The Huntington’s disease community’s unprecedented mobilization helped secure a high-priority FDA meeting to discuss the path forward for AMT-130.

Better Sleep, Better Function: New Study Links Sleep Quality to Clinical Outcomes in Huntington’s Disease

⏱️6 min read | Most people with HD report sleep problems, & new research suggests sleep quality is linked to many aspects of living with…

Keeping up with HD research just got easier: Introducing the HDBuzz Trial Tracker

⏱️6 min read | Ever wonder when to expect the next update from a clinical trial for Huntington’s disease? The HDBuzz Trial Tracker puts future…

Vaccines and Neurodegeneration: Lessons for Huntington’s Disease?

A recent article in the scientific journal, Nature describes “A natural experiment on the effect of herpes zoster (shingles) vaccination on dementia”. This study makes similar…

1 … 16 17 18 19 20 … 58